- The Future of B-cell Activating Factor Antagonists in the Treatment of Systemic Lupus Erythematosus
-
Stohl W
- KMID: 2378084
- J Rheum Dis.
- 2017 Apr;24(2):65-73.
- doi: 10.4078/jrd.2017.24.2.65
To review B-cell activating factor (BAFF)-antagonist therapy in systemic lupus erythematosus (SLE), literature was searched using the search words and phrases, “BAFFâ€, “B lymphocyte stimulator (BLyS)â€, “a proliferation-inducing ligand (APRIL)â€,... -
- CITED
-
- Close
- SHARE
-
- Close
